Search within:  

Sort results by:      



1-20 of 62   Next >
 
1.  
Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198). 2010 Aug (revised 2012 Feb). NGC:009080
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
3.  
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor. 2007 Aug (revised 2010 Aug). NGC:008062
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Certolizumab pegol for the treatment of rheumatoid arthritis. 2010 Feb. NGC:008061
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Rheumatoid arthritis: diagnosis, management and monitoring. 2012 Sep 30. NGC:009497
Medical Services Commission, British Columbia - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain. 2001 (revised 2011 Dec). NGC:009044
Advanced Research Techniques in the Health Services - For Profit Research Organization; Spanish Society of Rheumatology - Medical Specialty Society. View all guidelines by the developer(s)
8.  
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis. 2011. NGC:009433
British Health Professionals in Rheumatology - Professional Association; British Society for Rheumatology - Medical Specialty Society. View all guidelines by the developer(s)
9.  
Management of early rheumatoid arthritis. A national clinical guideline. 2000 Dec (revised 2011 Feb). NGC:008789
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Best evidence statement (BESt). Screening for uveitis in children with juvenile idiopathic arthritis (JIA). 2012 Jun 18. NGC:009274
Cincinnati Children's Hospital Medical Center - Hospital/Medical Center. View all guidelines by the developer(s)
12.  
Genetic considerations for a woman's pre-conception evaluation. 2011 Jan. NGC:008258
Society of Obstetricians and Gynaecologists of Canada - Medical Specialty Society. View all guidelines by the developer(s)
13.  
Denosumab for the prevention of osteoporotic fractures in postmenopausal women. 2010 Oct. NGC:008293
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
ACR Appropriateness Criteria® limping child — ages 0-5 years. 1995 (revised 2012). NGC:009219
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
15.  
Management of chronic venous leg ulcers. A national clinical guideline. 1998 Jul (revised 2010 Aug). NGC:008077
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Espoguia (clinical guidelines for patients with spondyloarthritis). 2010. NGC:008550
Spanish Society of Rheumatology - Medical Specialty Society. View all guidelines by the developer(s)
17.  
ACR Appropriateness Criteria® chronic foot pain. 1998 (revised 2013). NGC:010154
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
18.  
Management and prevention of osteoporosis. 2003 Oct (revised 2014 Jan). NGC:010233
Michigan Quality Improvement Consortium - Professional Association. View all guidelines by the developer(s)
19.  
20.  
Osteoporosis: assessing the risk of fragility fracture. 2012 Aug. NGC:009309
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 62   Next >